‘His Hands are Dirty in This’: Josh Hawley Calls Out Dr. Fauci at COVID-19 Whistleblower Hearing
You said in your opening statement that Dr. [Anthony] Fauci intervened to put his thumb on the scale of what information the the intelligence community could review [about the Wuhan lab leak theory] in when they did their initial assessments of whether or not the Wuhan lab was linked to [COVID-19.] So he reached […]
AI Designed a Universal Coronavirus Vaccine for Viruses Not Yet in Existence
University of Cambridge researchers have developed what they describe as a “fundamentally new” type of vaccine designed exclusively using artificial intelligence (AI), marking the first time a vaccine’s active antigen was created entirely through computational modeling and tested in humans. The vaccine candidate, pEVAC-PS, was developed by DIOSynVax Ltd., a biotechnology company founded out of […]
OB-GYN Trade Group Breaks with CDC and Makes Own Maternal Vaccination Recommendations
The American College of Obstetricians & Gynecologists (ACOG) has split from the U.S. Centers for Disease Control and Prevention (CDC) for the first time ever, releasing its own 2026 recommended maternal vaccine schedule.1 2 The new schedule is endorsed by 13 medical societies and health organizations including the American Academy of Family Physicians (AAFP) and […]
Merck Settles Gardasil Vaccine Injury Lawsuit for $50 Million
Merck & Co has agreed to pay 50 million dollars to settle more than 200 lawsuits brought against the drug giant by patients suffering from autoimmune disorders after receiving the Gardasil vaccine. According Merck, this settlement resolves all but one of the pending lawsuits filed against its HPV vaccine.1 Gardasil was fast-tracked to licensure by […]
FDA Panel Backs mFlusiva mRNA Flu Shot for Elderly
Despite a number of significant limitations in the available safety and efficacy data for licensure review of Moderna, Inc.’s new mRNA influenza biologic mFlusiva, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee ((VRBPAC) voted on June 18, 2026 to recommend fast-tracked licensure of the first mRNA product to target […]
FDA Set to Review Moderna’s mFlusiva mRNA Flu Shot
An mRNA (messenger ribonucleic acid) influenza biologic developed by Moderna, Inc. is scheduled to be reviewed today by a U.S. Food and Drug Administration (FDA) advisory panel. The Vaccines and Related Biological Products Advisory Committee ((VRBPAC) will evaluate data on Moderna’s mFlusiva (formerly known as mRNA-1010) to determine if the product provides superior relative vaccine […]